Stock screenerAll disclosures →
EDGAR →
IMVT
Conviction 43HealthcareScan · Thu, Sep 24, 2026Immunovant, Inc. (IMVT) closed at $34.03 (-1.49%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 27, RS Rating 95, -24.3% from its 52-week high, +31.3% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
IMVT$34.03-1.49%
ResistanceSupportVol 14Insider sell8
Vol MA14 1.61M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price34.03
Change-1.49%
Gap-1.04%
Rel volume1.42×
Avg volume1.5M
Avg $ vol56.62M
SMA 2038.29
SMA 5039.88
SMA 20031.47
Price vs 50-14.69%
Price vs 200+8.13%
MA stackmixed
50/200 cross—
Supertrenddown · 38.65
RSI (14)27
MACD hist-0.42
MACD cross—
Stoch %K / %D9 / 16
ADX (14)19
+DI / −DI16 / 32
RSI divergence—
MACD divergence—
ATR %4.55%
ADR %3.89%
52w high44.96
52w low15.46
From 52w high-24.32%
Above 52w low+120.08%
New 52w highNo
SqueezeOff
Bollinger width23.04%
%B0.02
Donchian pos6.28%
Donchian high43.95
Donchian low33.36
AVWAP (52w high)38.96
vs AVWAP high-12.66%
AVWAP (52w low)28.85
vs AVWAP low+17.93%
OBV trendDown
Chaikin MF (20)-0.17
Today vs 20d1.42×
Avg vol (14d)1.61M
Avg vol (20d)1.5M
Avg $ vol (20d)56.62M
Market cap7.03B
RS Rating95 / 99
RS 3m (vs SPY)-15.51%
RS 6m (vs SPY)+20.60%
RS line new highNo
Trend template6/8
Technical rank54.5
1 week-9.63%
1 month-21.78%
3 months-11.02%
6 months+37.42%
1 year+128.36%
YTD+31.32%
P/E-13.90
P/B9.56
P/S—
P/FCF-17.25
EPS-2.77
Div yield—
ROE-68.75%
ROA-59.31%
Debt/Eq—
Current7.27
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-22.17%
Price target51.89
Target upside52.51%
Analyst ratingBuy
Institutional57.37%
Ent. value6.23B
Revenue—
Net income-153.22M
Gross profit—
Free cash flow-407.32M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out205.31M
Employees315
ListedFri, Jun 21, 2019
Free float79.09M
Float %38.9%
Short interest15.78M
Days to cover14.1d
Short volume74.7%
Squeeze score91 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.75 vs −$0.66
Last surprise-13.6% miss
Setup gradeD
Conviction43 / 100
Pattern quality—
Tech rank54.5 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance42.99
Support36.45
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Immunovant stock edges lower after recent clinical pipeline focusAD HOC NEWS · Tue, Sep 22, 2026
- Behavioral Patterns of IMVT and Institutional FlowsStock Traders Daily · Tue, Sep 22, 2026
- Immunovant stock holds gains as investors eye upcoming data and recent revenue growthAD HOC NEWS · Sun, Sep 20, 2026
Congress activity
Disclosed STOCK Act trades in IMVT
No recent disclosed trades by Congress in IMVT. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in IMVT · open-market 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Pande Atul Director · Common Stock · 2026-08-28 | Exercise | 1.5K | $13K | 2026-08-28 | 2026-08-28 |
Pande Atul Director · Common Stock · 2026-08-28 | Sell | 1.5K | $65K | 2026-08-28 | 2026-08-28 |
Pande Atul Director · Stock Option (right to buy) · 2026-08-28 | Exercise | 1.5K | — | 2026-08-28 | 2026-08-28 |
Gloria Melanie Chief Operating Officer · Common Stock · 2026-08-20 | Sell | 3.06K | $135K | 2026-08-20 | 2026-08-21 |
Gloria Melanie Chief Operating Officer · Common Stock · 2026-07-08 | Sell | 1.93K | $76K | 2026-07-08 | 2026-07-10 |
Gloria Melanie Chief Operating Officer · Common Stock · 2026-07-08 | Sell | 106 | $4K | 2026-07-08 | 2026-07-10 |
Stout Jay S Chief Technology Officer · Common Stock · 2026-07-08 | Sell | 1.91K | $75K | 2026-07-08 | 2026-07-10 |
Stout Jay S Chief Technology Officer · Common Stock · 2026-07-08 | Sell | 105 | $4K | 2026-07-08 | 2026-07-10 |
Stout Jay S Chief Technology Officer · Common Stock · 2026-07-08 | Sell | 1.4K | $55K | 2026-07-08 | 2026-07-10 |
Stout Jay S Chief Technology Officer · Common Stock · 2026-07-08 | Sell | 77 | $3K | 2026-07-08 | 2026-07-10 |
SEC filings
EDGAR filings in IMVT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.